Reckitt could face £775m fine over Gaviscon ‘abuse of position’ – The Times

“The maker of Gaviscon indigestion medicine is alleged to have removed one version of the drug from NHS lists to encourage doctors to prescribe a more expensive variety. The Office of Fair Trading said yesterday that Reckitt Benckiser had abused its bestselling position in the market for supplying heartburn medicines to the NHS.”

Full story

The Times, 24th February 2010

Source: www.timesonline.co.uk

0 Responses to “Reckitt could face £775m fine over Gaviscon ‘abuse of position’ – The Times”



  1. Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s




February 2010
M T W T F S S
1234567
891011121314
15161718192021
22232425262728

Categories


%d bloggers like this: